Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Efficacy of TECAR Therapy on Patient With Mechanical Neck Pain

8 de septiembre de 2026 actualizado por: Mohamed A. Abdel Ghafar, Batterjee Medical College

Influence of TECAR Therapy on Cervical Mobility and Functional Disability in Patients With Mechanical Neck Pain: Randomized Control Study

The goal of this clinical trial is to evaluate the effectiveness of TECAR therapy in improving pain intensity, cervical range of motion, and functional disability in individuals with mechanical neck pain. It will also assess whether TECAR therapy provides additional clinical benefits compared with conventional physical therapy treatment. The main questions it aims to answer are:

  • Does TECAR therapy reduce pain intensity in patients with mechanical neck pain?
  • Does TECAR therapy improve cervical range of motion (CROM)?
  • Does TECAR therapy reduce functional disability as measured by the Neck Disability Index (NDI)? Researchers will compare participants receiving TECAR therapy combined with conventional physical therapy to participants receiving conventional physical therapy alone to determine the effectiveness of TECAR therapy in managing mechanical neck pain.

Participants will:

  • Attend scheduled treatment sessions during the study period
  • Receive either TECAR therapy with conventional physical therapy or conventional physical therapy alone
  • Undergo assessment of pain intensity, cervical range of motion, and neck disability before and after treatment

Descripción general del estudio

Estado

Reclutamiento

Intervención / Tratamiento

Descripción detallada

Mechanical neck pain is one of the most common musculoskeletal disorders and is frequently associated with pain, restricted cervical mobility, and reduced functional performance, which may negatively affect daily activities and quality of life. Conventional physical therapy interventions are commonly used to manage mechanical neck pain; however, interest has recently increased in the use of TECAR therapy as a non-invasive modality that may enhance tissue healing, improve circulation, reduce pain, and restore function.

This single-blind randomized controlled trial aims to investigate the clinical effectiveness of TECAR therapy in individuals with mechanical neck pain. Participants who meet the eligibility criteria will be randomly assigned to either an experimental group receiving TECAR therapy in combination with conventional physical therapy or a control group receiving conventional physical therapy alone.

Outcome measures will be assessed before and after the intervention period and will include pain intensity, cervical range of motion (CROM), and functional disability using the Neck Disability Index (NDI). The study seeks to determine whether adding TECAR therapy to a conventional rehabilitation program provides superior improvements in pain reduction, cervical mobility, and functional outcomes in patients with mechanical neck pain.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

40

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Mohamed A Abdel Ghafar, Ph.D.
  • Número de teléfono: 00966531513909
  • Correo electrónico: Pt12.jed@bmc.edu.sa

Ubicaciones de estudio

    • Al Zahraa
      • Jeddah, Al Zahraa, Arabia Saudita, 23623
        • Reclutamiento
        • Saudi German Hospital

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Presence of neck pain for at least 3 months
  • Limited cervical range of motion associated with neck pain
  • Ability to understand and follow study instructions Willingness to participate and sign the informed consent form

Exclusion Criteria:

  • History of cervical spine surgery or fracture
  • Cervical radiculopathy or other neurological disorders
  • Presence of inflammatory, rheumatic, or systemic diseases affecting the cervical spine

Severe cervical disc prolapse or spinal instability Current participation in another treatment program for neck pain Pregnancy Presence of pacemakers, metal implants, or contraindications to TECAR therapy Skin disorders or open wounds in the treatment area

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: TECAR Therapy Group for Mechanical Neck Pain
Participants will receive TECAR therapy combined with a conventional physical therapy program for mechanical neck pain.
Participants in the TECAR group received TECAR therapy in capacitive and resistive modes targeting superficial and deep tissues of the affected area. Each session lasted 20-30 minutes, with intensity adjusted to produce a comfortable thermal effect without pain. TECAR therapy was applied three times/week for 12 weeks, alongside a standardized exercise program identical to the control group.
Participants in the control group received a standardized therapeutic exercise program. The program included stretching, strengthening, and functional exercises targeting the affected region. Each session lasted 20-30 minutes and was performed three times/week for 12 weeks.
Comparador activo: Conventional Physical Therapy Group for Mechanical Neck Pain
Participants will receive a conventional physical therapy program only.
Participants in the control group received a standardized therapeutic exercise program. The program included stretching, strengthening, and functional exercises targeting the affected region. Each session lasted 20-30 minutes and was performed three times/week for 12 weeks.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Pain Intensity
Periodo de tiempo: Assessments will be conducted at baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)
Pain intensity was measured using the Visual Analog Scale (VAS) to assess changes in neck pain intensity throughout the study period. The VAS is a self-reported pain assessment tool consisting of a 10-cm horizontal line, with scores ranging from 0 to 10, where 0 indicates "no pain" and 10 indicates "worst imaginable pain." Higher scores represent greater pain intensity and therefore a worse outcome.
Assessments will be conducted at baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Cervical Range of Motion (CROM)
Periodo de tiempo: Baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)
Measured using a Cervical Range of Motion device to evaluate changes in cervical flexion, extension, lateral flexion, and rotation.
Baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)
Functional Disability
Periodo de tiempo: Assessment will be conducted at baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)
Functional disability was measured using the Neck Disability Index (NDI) to assess changes in functional limitations associated with mechanical neck pain. The NDI is a self-administered questionnaire consisting of 10 items related to daily activities and pain. Each item is scored from 0 to 5, with a total score ranging from 0 to 50, where 0 indicates no disability and 50 indicates complete disability. Higher scores represent greater functional disability and therefore a worse outcome.
Assessment will be conducted at baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

9 de julio de 2026

Finalización primaria (Estimado)

30 de septiembre de 2026

Finalización del estudio (Estimado)

25 de octubre de 2026

Fechas de registro del estudio

Enviado por primera vez

13 de mayo de 2026

Primero enviado que cumplió con los criterios de control de calidad

13 de mayo de 2026

Publicado por primera vez (Actual)

19 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

10 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

8 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • BMCSGHTECAR

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir